Published in J Comp Neurol on September 08, 1985
Photostimulation of channelrhodopsin-2 expressing ventrolateral medullary neurons increases sympathetic nerve activity and blood pressure in rats. J Physiol (2009) 1.40
Complete nucleotide and deduced amino acid sequence of bovine phenylethanolamine N-methyltransferase: partial amino acid homology with rat tyrosine hydroxylase. Proc Natl Acad Sci U S A (1986) 1.34
Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina. Proc Natl Acad Sci U S A (1988) 1.22
Dopamine/Tyrosine Hydroxylase Neurons of the Hypothalamic Arcuate Nucleus Release GABA, Communicate with Dopaminergic and Other Arcuate Neurons, and Respond to Dynorphin, Met-Enkephalin, and Oxytocin. J Neurosci (2015) 0.88
The mammalian diving response: an enigmatic reflex to preserve life? Physiology (Bethesda) (2013) 0.86
Posterior fossa brain tumors and arterial hypertension. Neurosurg Rev (2006) 0.82
Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism. Cell Mol Neurobiol (2004) 0.81
Phenylethanolamine N-methyltransferase-containing neurons in the limbic system of the young rat. Proc Natl Acad Sci U S A (1989) 0.75
Hypothalamic vasotocin and tyrosine hydroxylase levels following maternal care and selection for low mortality in laying hens. BMC Vet Res (2014) 0.75
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49
Microsatellite evolution--evidence for directionality and variation in rate between species. Nat Genet (1995) 4.77
Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci (1988) 4.47
Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med (2001) 4.22
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science (2001) 4.13
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet (1999) 4.06
Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand (2005) 3.96
Antigenic relationship of varicella-zoster and herpes simplex. Lancet (1965) 3.33
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet (2000) 3.07
Agmatine: an endogenous clonidine-displacing substance in the brain. Science (1994) 2.83
Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology (2004) 2.81
Synthesis of nitric oxide in CNS glial cells. Trends Neurosci (1993) 2.81
Influenza, respiratory syncytial virus, and pneumonia in Glasgow, 1962-5. Br Med J (1967) 2.76
A huntingtin-associated protein enriched in brain with implications for pathology. Nature (1995) 2.67
Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry (2007) 2.53
Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet (1999) 2.53
Anticipation in bipolar affective disorder. Am J Hum Genet (1993) 2.44
Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet (1998) 2.39
A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry (2005) 2.32
Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum Mol Genet (1997) 2.28
Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem (1998) 2.23
Two-year follow-up of inpatients with dissociative identity disorder. Am J Psychiatry (1997) 2.18
Basic research by medical students. J R Soc Med (1981) 2.15
Clinical markers of early disease in persons near onset of Huntington's disease. Neurology (2001) 2.11
The inositol 1,4,5,-trisphosphate receptor in cerebellar Purkinje cells: quantitative immunogold labeling reveals concentration in an ER subcompartment. J Cell Biol (1990) 2.03
Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet (1993) 2.00
Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis (1998) 1.96
Millon Clinical Multiaxial Inventory--II. Follow-up of patients with dissociative identity disorder. Psychol Rep (1996) 1.95
Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci (2000) 1.92
Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science (1996) 1.92
Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A (1989) 1.87
Validity of the Dissociative Experiences Scale in screening for multiple personality disorder: a multicenter study. Am J Psychiatry (1993) 1.87
Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med (1999) 1.86
Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci U S A (1992) 1.80
Inositol 1,4,5-trisphosphate receptors: distinct neuronal and nonneuronal forms derived by alternative splicing differ in phosphorylation. Proc Natl Acad Sci U S A (1991) 1.76
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet (2001) 1.74
Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat Genet (1999) 1.74
Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord (2000) 1.67
Fluid lamellar keratoplasty in keratoconus. Ophthalmology (2000) 1.65
The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience (1985) 1.64
Spontaneous waves of cerebral blood flow associated with a pattern of electrocortical activity. Am J Physiol (1994) 1.62
Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther (1990) 1.61
Subcortical efferent projections of the medial geniculate nucleus mediate emotional responses conditioned to acoustic stimuli. J Neurosci (1984) 1.57
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiol Dis (2001) 1.57
Topographic organization of neurons in the acoustic thalamus that project to the amygdala. J Neurosci (1990) 1.56
A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet (2001) 1.56
Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology (1997) 1.56
Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A (1990) 1.55
Transneuronal regulation of tyrosine hydroxylase expression in olfactory bulb of mouse and rat. J Neurosci (1983) 1.54
Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. Mol Cell Neurosci (1998) 1.53
The role of the solitary and paramedian reticular nuclei in mediating cardiovascular reflex responses from carotid baro- and chemoreceptors. J Physiol (1972) 1.53
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51
Herpes zoster in general practice. J R Coll Gen Pract (1975) 1.51
Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49
Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disord (1997) 1.49
Infective agents and embryopathy in the west of Scotland 1966-1970. Scott Med J (1972) 1.48
Rostral ventrolateral medulla: selective projections to the thoracic autonomic cell column from the region containing C1 adrenaline neurons. J Comp Neurol (1984) 1.48
Hypertension and a tumor of the glomus jugulare region. Evidence for epinephrine biosynthesis. Am J Hypertens (1993) 1.47
Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J Neurosci (1999) 1.47
Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. Genomics (1993) 1.47
The active site and mechanism of action of bovine pancreatic ribonuclease. 7. The catalytic mechanism. Biochem J (1962) 1.47
Schizophrenia: a disease of heteromodal association cortex? Neuropsychopharmacology (1996) 1.47
Distribution of carotid sinus and depressor nerves in cat brain stem. Am J Physiol (1968) 1.46
Immunochemical demonstration of increased accumulation of tyrosine hydroxylase protein in sympathetic ganglia and adrenal medulla elicited by reserpine. Proc Natl Acad Sci U S A (1973) 1.46
Specific IgM antibody in serum of patients with herpes zoster infections. Br Med J (1972) 1.45
The trigeminal depressor response: a novel vasodepressor response originating from the trigeminal system. Brain Res (1977) 1.44
The Valsalva DCR bubble test: a new method of assessing lacrimal patency after DCR surgery. Ophthal Plast Reconstr Surg (1994) 1.44
Serum ferritin levels in carriers of beta-thalassaemia trait. Acta Haematol (1995) 1.43
Detection of a large CTG/CAG trinucleotide repeat expansion in a Danish schizophrenia kindred. Am J Med Genet (1997) 1.42
Monoamine-synthesizing enzymes in central dopaminergic, noradrenergic and serotonergic neurons. Immunocytochemical localization by light and electron microscopy. J Histochem Cytochem (1976) 1.40
Herpes simplex and temporal lobe epilepsy. Br Med J (1972) 1.40
Projections to the subcortical forebrain from anatomically defined regions of the medial geniculate body in the rat. J Comp Neurol (1985) 1.40
Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry (2011) 1.39
Nuclear targeting of mutant Huntingtin increases toxicity. Mol Cell Neurosci (1999) 1.39
Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol (1993) 1.39
The prevalence and biometric structure of pathological dissociation in the general population: taxometric and behavior genetic findings. J Abnorm Psychol (1997) 1.39
Frontal lobe volume in patients with Huntington's disease. Neurology (1998) 1.38
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol (1990) 1.37
Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. J Comp Neurol (1999) 1.37
Encephalitis. A four-year survey. Lancet (1968) 1.37
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer. Br J Cancer (2009) 1.36
Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature (1993) 1.36
Infective agents and chronic bronchitis. Thorax (1966) 1.36
Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol (1987) 1.36
Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol (2000) 1.36